Complementing the Expanded Biopharmaceutical Platform Solution are New Charged Surface Hybrid Particle Column and GlycoWorks Kit for Glycan Preparation
WASHINGTON - Waters Corporation (NYSE: WAT) today reinforced its commitment to advancing biotherapeutic characterization technology at the Well Characterized Biotechnology Pharmaceuticals 2013 Symposium (WCBP 2013). More specifically, Waters® today introduced an expansion of its Biopharmaceutical Platform Solution with UNIFI®, new ACQUITY ...This story is related to the following:Laboratory and Research Supplies and EquipmentHealth, Medical and Dental Supplies and EquipmentSearch for suppliers of: Liquid Chromatograph-Mass Spectrometers (LC/MS) Combined |